What is private in Pharmaceutical, Life Science and Biotech Law? Challenge Seminar with Professor Timo Minssen

Gigone, F. (Deltager)

Aktivitet: Deltagelse i eller arrangement af en begivenhed › Deltagelse i workshop, seminar og kursus

Periode	12 dec. 2018
Begivenhedstype	Seminar
Placering	Copenhagen, DanmarkVis på kort
Grad af anerkendelse	National

Dokumenter og Links

"Biomedical innovation is experiencing changes of epic proportions. Rapid progress in many scientific areas, such as gene editing, pharmacogenomics, artificial intelligence and big data-driven precision medicine have greatly advanced the promises and opportunities of the health and life sciences. But these advances also pose a many regulatory challenges. The overall aim and ambition of our research at CeBIL is to contribute to the translation of groundbreaking biomedical research into safe, effective, affordable and accessible therapies by analyzing the most significant legal challenges to pharmaceutical innovation and public health from a cross-disciplinary perspective. Within this trajectory, privacy is extremely relevant in many context, such as when immense amounts of healthcare data are gathered to develop new therapies and train algorithms, and where such data is then shared to oversee it. In each case, patient-oriented data privacy is a concern. Recently enacted European legislation (GDPR) and US legislation (CPA) places strict constraints on the type of patient and health data that can processed. During our seminar I will describe CeBIL’s research and illustrate where, why and how privacy is important in order to identify potential collaboration between PRIVACY and CeBIL."